Skip to main content
. 2018 Oct;10(10):5913–5923. doi: 10.21037/jtd.2018.10.41

Figure 5.

Figure 5

Macrolide therapy can significantly reduce endoscopic scores compared to control groups at both the 8-week visit and the 12-week visit in cohort trials. (A) In cohort trials, compared to control groups at the 8-week visit, the endoscopic scores were significantly reduced in the macrolide treated groups (P<0.00001). (B) At the 12-week visit, the endoscopic scores were significantly different between macrolide treated groups and baseline in cohort trials (P<0.00001).